AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TIOTROPIUM

11 registrations across 3 African markets— 7 active

Markets with TIOTROPIUM

Recent registrations

Brand / ProductMarketHolderStatusExpires
RESPYVA
Poudre pour inhalation buccale / 18 µg
🇹🇳TunisiaNEAPOLIS PHARMAexpiredMay 2023
XTIOVA EASY FLOW
Poudre pour inhalation buccale / 18 mcg
🇹🇳TunisiaOPALIA PHARMAexpiredSept 2020
SPIRIVA
Poudre pour inhalation buccale / 18 mcg
🇹🇳TunisiaBOEHRINGER ING.INT.GmbHexpiredAug 2009
SPIRIVA
Poudre pour inhalation buccale / 18 mcg
🇹🇳TunisiaBOEHRINGER ING.INT.GmbHexpiredAug 2009
SPIRIVA
GELULE INHALEE
🇲🇦Moroccoactive
TIOTRO-GH
Gélule / 18µg
🇸🇳Senegalactive
TIOTRO-GH
Gélule / 18µg
🇸🇳Senegalactive
NEUMOTROPIO
capsule / 10 mcg
🇸🇳SenegalEXELTIS HEALTHCAREactive
SPIRIVA 18 µG
GELULE INHALEE
🇲🇦Moroccoactive
SPIRIVA 18 µG
GELULE INHALEE
🇲🇦Moroccoactive
SPIRIVA
GELULE INHALEE
🇲🇦Moroccoactive

TIOTROPIUM in Africa — Regulatory Overview

TIOTROPIUM is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 7 (64%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.